2018
DOI: 10.21320/2500-2139-2018-11-2-175-181
|View full text |Cite
|
Sign up to set email alerts
|

Evolution of Anti-Cancer Treatment and its Impact on Surrogate Prognostic Factors in Multiple Myeloma

Abstract: Цель. Оценить прогностическое значение отдельных суррогатных клинико-лабораторных маркеров у пациентов со множественной миеломой (MM) при проведении современной терапии.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 14 publications
0
0
0
Order By: Relevance